References
- Alexander FE, Anderson TJ, Brown HK, et al (1999). 14 years of follow-up from the Edinburgh randomized trial of breast cancer screening. Lancet, 353, 1903-8. https://doi.org/10.1016/S0140-6736(98)07413-3
- Altekruse SF, Kosary CL, Krapcho M, et al (2007). SEER Cancer Statistics Review, 1975-2007, National Cancer Institude. Bethesda, MD.
- Anderson BO, Distelhorst SR (2008). Guidelines for international breast health and cancer-control implementation. Introduction. Cancer, 15, 2215-6.
- Andersson I, Aspegren K, Janzon L, et al (1988). Mammographic screening and mortality from breast cancer: the Malmo mammographic screening- trial. BMJ, 297, 943-8. https://doi.org/10.1136/bmj.297.6654.943
- Andersson I, Janzon L (1997). Reduced breast cancer mortality in women under age 50:updated results from the Malmo Mammographic Screening program. J Natl Cancer Inst Monogr, 22, 63-7.
- Bassett LW, Hendrick RE, Bassford TL (1994). Quality determinants of mammography. In: Clinical practice guideline no. 13: AHCPR publication no. 95-0632. Rockville, Md: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services.
- Beam CA, Conant EF, Sickles EA (2003). Association of volume and volume independent factors with accuracy in screening mammogram interpretation. J Natl Cancer Inst, 95, 282-90. https://doi.org/10.1093/jnci/95.4.282
- Bjurstam N, Bjorneld L, Warwick J, et al (2003). The gothenburg breast cancer screening trial. Cancer, 97, 2387-96. https://doi.org/10.1002/cncr.11361
- Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 10, 1002.
- Frisell J, Eklund G, Hellstrom L, et al (1991). Randomisedstudy of mammographic screening: preliminary report on mortality in the Stockholmtrial. Breast Cancer Res Treat, 18, 49-56. https://doi.org/10.1007/BF01975443
- Gilliland FD, Joste N, Stauber PM, et al (2000). Biologic characteristics of interval and screen-detected breast cancers. J Natl Cancer Inst, 92, 743-9. https://doi.org/10.1093/jnci/92.9.743
- Glasziou P, Houssami N (2011). The evidence base for breast cancer screening. Prev Med, 53, 100-2. https://doi.org/10.1016/j.ypmed.2011.05.011
- Gnerlich JL, Deshpande AD, Jeffe DB, et al (2009). Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease. J Am Coll Surg, 208, 341-7. https://doi.org/10.1016/j.jamcollsurg.2008.12.001
- Groenendijk RP, Bult P, Tewarie L, et al (2000). Screen- detected breast cancers have a lower mitotic activity index. Br J Cancer, 82, 381-4. https://doi.org/10.1054/bjoc.1999.0930
- Harris R, Yeatts J, Kinsinger L (2011). Breast cancer screening for women ages 50 to 69 years a systematic review of observational evidence. Prev Med, 53, 108-14. https://doi.org/10.1016/j.ypmed.2011.07.004
- Joensuu H, Lehtimaki T, Holli K, et al (2004). Risk for distant recurrence of breast cancerdetected by mammography screening or other methods. JAMA, 292, 1064-73. https://doi.org/10.1001/jama.292.9.1064
- Larsson LG, Andersson I, Bjurstam N, et al (1997). Updated overview of the Swedish randomized trials on breast cancer screening with mammography: age group 40-49 at randomization. J Natl Cancer Inst Monogr, 22, 57-61.
- Liston J, Wilson R (2005). Quality assurance guidelines for breast cancer screeningradiology. NHS Breast Screening Programmes publication no. 59. Sheffield, England:NHS Cancer Screening Programmes, January 2005.
- Moss SM, Cuckle H, Evans A, et al (2006). Trial Management Group. Effect of mammographic screening from age 40 years on breast cancermortality at 10 years' follow-up: a randomised controlled trial. Lancet, 368, 2053-60. https://doi.org/10.1016/S0140-6736(06)69834-6
- Nystrom L, Rutqvist L, Wall S, et al (1993). Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet, 341, 973-8. https://doi.org/10.1016/0140-6736(93)91067-V
- Nystrom L, Andersson I, Bjurstam N, et al (2002). Long-term effects of mammography screening: upated overview of the Swedish randomized trials. Lancet, 359, 909-19. https://doi.org/10.1016/S0140-6736(02)08020-0
- Olivotto IA, Kan L, d'Yachkova Y, et al (2000). Ten years of breast screening in the Screening Mammography Program of British Columbia, 1988-97. J Med Screen, 7, 152-9. https://doi.org/10.1136/jms.7.3.152
- Ozmen V (2008). Breast cancer in the world and Turkey. J Breast Hlth, 4, 7-12.
- Ozmen V (2012). Turkiye'de Meme Kanseri, Turkiye Meme Hastaliklari Federasyonu, Ulusal Meme Kanseri Veri Tabani Verilerinin Analizi. 2012, Istanbul.
- Ozmen V, Anderson BO (2008). The challenge of breast cancer in low and middle income countries implementing the Breast Health Global Initiative Guidelines. Asia Pac Oncol and Haematol, 1, 31-4.
- Ozmen V, Ozaydin AN, Cabioglu N, et al (2011). Survey on pilot mammographic screening program in Istanbul, Turkey. Breast J, 17, 260-7. https://doi.org/10.1111/j.1524-4741.2011.01065.x
- Perry N, Broeders M, deWolf C, Tornberg S (2001). European guidelines for quality assurance in mammography screening. 3rd ed. Luxembourg: European Commission.
- RSHMB (2004). www.tusak.saglik.gov.tr/pdf 2004.
- Reston VA (2003). Illustrated breast imaging reporting and data system (BI-RADS). In:American College of Radiology (ACR), 4th edn 2003:234.
- Schopper D, de Wolf, C (2009). How effective are breast cancer screening programmes by mammography? Review of the current evidence. Eur J Cancer, 45, 1916-23. https://doi.org/10.1016/j.ejca.2009.03.022
- Sickles EA, Wolverton DE, Dee KE (2002). Performance parameters for screening and diagnostic mammography: specialist and general radiologists. Radiology, 224, 861-9. https://doi.org/10.1148/radiol.2243011482
- Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov): SEER* Stat Database: Incidence- SEER 9 Regs Public Use, Nov 2005 Sub (1973-2003), National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch.
- Tabar L, Fagerberg CJ, Gad A, et al (1985). Reduction in mortality from breast cancer after mass screening with mammography: randomised trial from the Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet, 1, 829-32.
- UK Trial of Early Detection of Breast Cancer Group (1988). First results on mortalityreduction in the UK Trial of Early Detection of Breast Cancer Group. Lancet, 2, 411-6.
- US Preventive Services Task Force (2002). Screening for Breast Cancer: Recommendations and Rationale. Ann Intern Med, 137, 344-6. https://doi.org/10.7326/0003-4819-137-5_Part_1-200209030-00011
- US Preventive Services Task Force (2009). Screening for Breast Cancer: U.S. PreventiveServices Task Force Recommendation Statement. Ann Intern Med, 151, 716-26. https://doi.org/10.7326/0003-4819-151-10-200911170-00008
- Woolf SH (2010). The 2009 breast cancer screening recommendations of the US Preventive Services Task Force. Jama, 303, 162-3. https://doi.org/10.1001/jama.2009.1989
Cited by
- Prognostic Factors for Survival in Patients with Breast Cancer Referred to Omitted Cancer Research Center in Iran vol.16, pp.12, 2015, https://doi.org/10.7314/APJCP.2015.16.12.5081
- Health Beliefs of Nursing Faculty Students about Breast Cancer and Self Breast Examination vol.16, pp.17, 2015, https://doi.org/10.7314/APJCP.2015.16.17.7731
- Mammographic density assessed on paired raw and processed digital images and on paired screen-film and digital images across three mammography systems vol.18, pp.1, 2016, https://doi.org/10.1186/s13058-016-0787-0